India’s Generic Wave Hits Ozempic And Wegovy As Prices Drop Sharply

All NewsMarch 23, 2026

India’s drugmakers roll out low-cost copies for Novo Nordisk’s semaglutide, slashing prices up to 70% as analysts weigh global market disruption risks.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent